Skip to main content

Table 1 Signaling pathways associated with TS mediated by neuroinflammation

From: Neuroinflammation and pathways that contribute to tourette syndrome

Reference

Pathway

Function

Method

[116]

(Wu et al., 2023)

CaMKII/Drp1/ROS/NF-κB

Microglia activation

LPS-stimulated BV2 microglial cells

[117]

(Huang et al., 2008)

JAK2/STAT3

Mediating microglia activation and dopaminergic neuron degeneration

Thrombin-stimulated rat primary microglia

[118]

(Wu et al., 2022)

JAK2/STAT3/p65

Mediating neuroinflammation

LPS-stimulated mouse hippocampal CA1 region and BV2 cells

[119]

(Kim et al., 2006)

TLR4/STAT3

Inducing ICAM-1 expression, mediating microglia activation, pro-inflammatory actions

LPS-stimulated mice lacking functional TLR4

[120]

(Zeng et al., 2014)

Akt/IκB/

NF-κB

Mediating neuroinflammation

LPS-stimulated BV2 microglial cells

[121]

(Kang et al., 2012)

PI3K/Akt/

NF-κB

Inducing pro-inflammatory mediators, NO, PGE(2) and TNF-α, and their regulatory genes

LPS-stimulated BV2 microglial cells

[122]

(Hongyan et al., 2017a)

PI3K/Akt/

NF-κB

Increasing the levels of inflammatory cytokines, such as IL-6, IL-1β, and TNF-α, in the serum and striatum of rats

DOI-induced TS model in rats

[123]

(Hongyan et al., 2017b)

TLR/MyD88/NF-κB

Increasing the levels of inflammatory cytokines, such as IL-6, IL-1β, and TNF-α, in the serum and striatum of rats

DOI-induced TS model in rats,

LPS-stimulated rats

[124]

(Long et al., 2019b)

BDNF/NF-κB

Decreasing the BDNF-mediated increase in NF-κB levels; increasing IL-6, IL-1β, and TNF-α levels in the serum, striatum, and cell supernatant of rats with TS

DOI-induced BV2 cells; DOI-induced TS model in rats

[125]

(Xu et al., 2017)

BDNF/TrkB/

MyD88/NF-κB

Increasing TrkB expression levels, activating downstream PI3K/AKT signaling after BDNF pretreatment; inhibiting the MyD88/NF-κB signaling pathway; promoting the inflammatory response and hippocampal apoptosis

Pretreatment with exogenous BDNF or the TrkB inhibitor; intracisternal infection with live Streptococcus pneumoniae

[126]

(Long et al., 2019a)

Nrf-2/HO‐1/HMGB1/NF‐кB

Mediating neuroinflammation

IPN-induced TS model in rats

[127]

(Chunhui et al., 2017)

EGF/EGFR/Nrf-2/HO‐1/ NF‐кB

Mediating inflammatory and oxidative injury

osteoblast cells

[128]

(Haddad, 2005)

NMDAR/

MAPK/CREB

Regulating the levels of amino acid neurotransmitters; mediating the activation of microglia

DOI-induced TS model in rats; LPS-stimulated BV2 microglial cells

[129]

(Hildonen et al., 2021)

PI3K/AKT/

mTOR

Affecting neuronal growth and proliferation; affecting the release of

dopamine

An exploratory analysis of the genome-wide DNA methylation patterns in whole-blood samples of 16 monozygotic twin pairs with TS

  1. Abbreviations: Akt: protein kinase B; BDNF: brain-derived neurotrophic factor; CaMKII: calcium-calmodulin dependent protein kinase II; CREB: cAMP-response element binding protein; DOI: 2,5-dimethoxy-4-iodoamphetamine; Drp1: dynamin-related protein 1; EGF: epidermal growth factor; EGFR: estimated glomerular filtration rate; HMGB1: high-mobility group protein B1; HO-1: heme oxygenase-1; ICAM-1: intercellular adhesion molecule-1; IL-1β: interleukin-1β; IL-6: interleukin-6;
  2. IPN: 3,3’-iminodipropionitrile; IκB: NF-κB inhibitory protein; JAK2: Janus kinase 2; LPS: lipopolysaccharide; MAPK: mitogen-activated protein kinase; mTOR: mammalian target of rapamycin; MyD88: myeloid differentiation primary response gene 88; NF-κB: Nuclear factor-kappa B; NMDAR: N-methyl-D-aspartate; NO: nitric oxide; Nrf‐2: nuclear factor erythroid 2-related factor 2; PGE(2): prostaglandin E2; PI3K: phosphoinositide 3-kinase; ROS: reactive oxygen species; STAT3: signal transducer and activator of transcription 3; TLR4: Toll-like receptor 4; TNF-α: tumor necrosis factor-α; TrkB: tropomyosin-receptor kinase; TS: Tourette syndrome